Cambridge AI-Designed Vaccine Moves to Human Trials

Cambridge AI-Designed Vaccine Moves to Human Trials

A New Frontier in Immunization Researchers at the University of Cambridge have successfully transitioned the world’s first artificial intelligence-designed vaccine into human clinical trials, marking a significant milestone in medical technology. This breakthrough, announced this week, represents the first time a fully AI-generated vaccine candidate has reached the human testing phase, aiming to combat complex…

Read More